Respiratory
Syncytial Virus (RSV) is responsible for many chronic
conditions such as pneumonia, bronchitis, asthma, and respiratory
disease. It primarily affects neonates, infants and adults and is
responsible for outpatient visits, hospitalization and death in some
cases. Therefore, diagnosis of RSV- associated diseases is crucial
to avoid further medical severity. Symptoms of RSV presence include,
rhinorrhea, cough, wheeze, respiratory distress, and hypoxemia.
Molecular diagnostic is most widely used techniques for diagnosing
RSV.
Respiratory
Syncytial Virus Diagnostics Market - Market Dynamics
High
prevalence of respiratory infections due to RSV is a major factor
driving growth of the respiratory syncytial virus diagnostics market.
According to a report by the Lancet, 2017, around 33·1 million
episodes of RSV induced acute lower respiratory infections that
resulted in around 3·2 million hospitalizations and around 59,600
in-hospital deaths in children younger than 5 years of age,
worldwide, in 2015. Moreover, the report stated that the overall RSV-
acute lower respiratory infections- related mortality was around
118200 in 2015.
Ask
for In-depth Sample Copy of This Research at
https://www.coherentmarketinsights.com/insight/request-sample/2038
Furthermore,
high prevalence of several chronic conditions such as pneumonia and
other respiratory tract infections due to RSV is a major factor
contributing to growth of the market over the forecast period. For
instance, according to a report by World Health Organization (WHO),
May 2018, chronic obstructive pulmonary disease (COPD) and lower
respiratory tract infection are amongst top five chronic diseases
with highest mortality rate, worldwide. The report stated that around
3 million each deaths were registered due to COPD and lower
respiratory tract infection in 2016, worldwide.
Respiratory
Syncytial Virus Diagnostics Market - Regional Insights
On
the basis of Geography, respiratory syncytial virus diagnostics
market is segmented into North America, Latin America, Europe, Asia
Pacific, Middle East, and Africa. North America is expected to be
dominant in the respiratory syncytial virus diagnostics market over
the forecast period. According to study published in journal American
Family Physician in 2017, around 2% to 3% of infants, younger than 12
months are hospitalized with an RSV infection, annually, in the U.S.
As per same source, Around 57,500 hospitalizations and 2.1 million
outpatient visits are associated with RSV infections in children
younger than five years, annually, in the U.S. It can be concluded
from epidemiological data that the U.S. has high potential for
respiratory syncytial virus diagnostics market. Presence of key
players and their products in North America would be another
important driver for the market growth.
Respiratory
Syncytial Virus Diagnostics Market - Competitive Landscape
Key
players operating in the respiratory syncytial virus diagnostics
market include, F. Hoffmann La-Roche AG , Becton, Dickinson and
Company, Novartis AG, Abbott Laboratories, Ortho Clinical
Diagnostics, Thermo Fisher Scientific Inc., Bio-Rad Laboratories
Inc., BioMerieux, DiaSorin SPA, Millipore-sigma, Quidel Corporation,
Alere Inc., Coris BioConcept, Fast-track Diagnostics, and Quest
Diagnostics.
Respiratory
Syncytial Virus Diagnostics Market - Market Taxonomy
- On
the basis of diagnostic techniques: Molecular Diagnostics, Direct
Fluorescent Antibody (DFA) Method, Rapid Antigen Diagnostic Test,
Monoclonal Antibodies, Flow Cytometry, Diagnostic Imaging,
Immnunochromgraphic Assay, Gel Microdroplets, Others
- On
the basis of end user: Hospitals, Diagnostic Centers, Commercial
Radioisotope Manufacturers
- On
the basis of region: North America, Latin America, Europe, Asia
Pacific, Middle East, Africa
Request
For Customization of Research Report @
https://www.coherentmarketinsights.com/insight/request-customization/2038
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm
offering action-ready syndicated research reports, custom market
analysis, consulting services, and competitive analysis through
various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact
Us:
Mr.
Shah
Coherent
Market Insights
1001
4th Ave,
#3200
Seattle,
WA 98154
Tel:
+1-206-701-6702
No comments:
Post a Comment